Volv Global sits at the crucial intersection between technology and human beings, i.e., patients and physicians, supporting favourable patient journeys and outcomes.
Meet us at the World Orphan Drug Congress USA 2025 in Boston, 22nd-25th April, to find out more:
🟥 Our booth: #413
🟥 Our Panel Discussion at 11.05 a.m., on Wednesday, 23rd April, in the AI & Digital Health Track, in Theater 3.
Where technology meets Human: Redefining Patient Personalisation
will discuss how technology may bring incredible benefits for health and healthcare, but how can the way be eased for the healthcare ecosystem – incl. patients, physicians, HCOs, health authorities and payers – to be able to fully embrace new advances? And, if adopted, what work is needed to ensure these innovations are sustained and continue?
We are very pleased to have leading lights of the industry on this panel with us:
🟥 Albert Freedman, Counseling Psychologist/ Rare Dad, RareCounseling.com,
🟥 Faisal Riaz, MD, Medical Director PDT, RAID/ Neuroimmunology, Takeda Pharmaceuticals,
🟥 Rachel Smith, Executive Director and Global Head, Rare Disease Center of Excellence, Parexel,
🟥 Joern-Peter Halle, Advisor and Venture Partner, BGV,
will join
🟥 Christopher Rudolf, Founder and Chief Executive Officer, Volv Global
🟥 Our Talk at 11.10 a.m., on Thursday, 24th April in the Global Market and Patient Access track, in Theater 4 – Room 050.
Where technology meets Human: Healthcare. Numbers. Money. People.
How can we in the healthcare ecosystem avoid technology pitfalls and bring the human being back into focus? Volv Global CEO Christopher Rudolf will touch on lessons in successful collaboration for international projects, with a focus on “Value and Access 2.0.”
Looking forward to having great discussions with you there! Please Contact Us to book a meeting!
